Loading...
Ras drives malignancy through stem cell crosstalk with the microenvironment
Yuan, Shaopeng Stewart, Katherine S. Yang, Yihao Abdusselamoglu, Merve Deniz Parigi, S. Martina Feinberg, Tamar Y. Tumaneng, Karen Yang, Hanseul Levorse, John M. Polak, Lisa
Yuan, Shaopeng
Stewart, Katherine S.
Yang, Yihao
Abdusselamoglu, Merve Deniz
Parigi, S. Martina
Feinberg, Tamar Y.
Tumaneng, Karen
Yang, Hanseul
Levorse, John M.
Polak, Lisa
Citations
Altmetric:
Genre
Journal article
Date
2022-11-30
Advisor
Committee member
Group
Department
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
http://dx.doi.org/10.1038/s41586-022-05475-6
Abstract
Squamous cell carcinomas are triggered by marked elevation of RAS–MAPK signalling and progression from benign papilloma to invasive malignancy1,2,3,4. At tumour–stromal interfaces, a subset of tumour-initiating progenitors, the cancer stem cells, obtain increased resistance to chemotherapy and immunotherapy along this pathway5,6. The distribution and changes in cancer stem cells during progression from a benign state to invasive squamous cell carcinoma remain unclear. Here we show in mice that, after oncogenic RAS activation, cancer stem cells rewire their gene expression program and trigger self-propelling, aberrant signalling crosstalk with their tissue microenvironment that drives their malignant progression. The non-genetic, dynamic cascade of intercellular exchanges involves downstream pathways that are often mutated in advanced metastatic squamous cell carcinomas with high mutational burden7. Coupling our clonal skin HRASG12V mouse model with single-cell transcriptomics, chromatin landscaping, lentiviral reporters and lineage tracing, we show that aberrant crosstalk between cancer stem cells and their microenvironment triggers angiogenesis and TGFβ signalling, creating conditions that are conducive for hijacking leptin and leptin receptor signalling, which in turn launches downstream phosphoinositide 3-kinase (PI3K)–AKT–mTOR signalling during the benign-to-malignant transition. By functionally examining each step in this pathway, we reveal how dynamic temporal crosstalk with the microenvironment orchestrated by the stem cells profoundly fuels this path to malignancy. These insights suggest broad implications for cancer therapeutics.
Description
Citation
Yuan, S., Stewart, K.S., Yang, Y. et al. Ras drives malignancy through stem cell crosstalk with the microenvironment. Nature 612, 555–563 (2022). https://doi.org/10.1038/s41586-022-05475-6
Citation to related work
Nature Research
Has part
Nature, Vol. 612
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu